Waters Corporation Appoints Heather Knight to Board of Directors
Waters (NYSE:WAT) has appointed Heather Knight to its Board of Directors, effective August 14, 2024. Knight, currently serving as Executive Vice President and Group President, Medical Products and Therapies at Baxter International, brings nearly three decades of experience in the pharmaceutical and medical device industries. Her appointment is expected to enhance the board's oversight of strategy and shareholder value.
Dr. Flemming Ornskov, Chair of the Board, praised Knight's proven track record in driving growth and innovation. Dr. Udit Batra, President and CEO of Waters , highlighted Knight's commitment to operational excellence and her global experience in commercial execution and portfolio innovation as complementary to the board's existing skills.
Waters (NYSE:WAT) ha nominato Heather Knight nel suo Consiglio di Amministrazione, con effetto dal 14 agosto 2024. Knight, attualmente Presidente Esecutivo e Presidente di Gruppo per Prodotti e Terapie Mediche presso Baxter International, porta con sé quasi tre decenni di esperienza nelle industrie farmaceutica e dei dispositivi medici. La sua nomina è destinata a migliorare la supervisione della strategia e del valore per gli azionisti da parte del consiglio.
Il Dr. Flemming Ornskov, Presidente del Consiglio, ha lodato il comprovato successo di Knight nel guidare la crescita e l'innovazione. Il Dr. Udit Batra, Presidente e CEO di Waters, ha sottolineato l'impegno di Knight per l'eccellenza operativa e la sua esperienza globale nell'esecuzione commerciale e nell'innovazione del portafoglio, come complementari alle competenze esistenti del consiglio.
Waters (NYSE:WAT) ha nombrado a Heather Knight en su Junta Directiva, con efecto desde el 14 de agosto de 2024. Knight, que actualmente se desempeña como Vicepresidente Ejecutivo y Presidente de Grupo de Productos y Terapias Médicas en Baxter International, aporta casi tres décadas de experiencia en las industrias farmacéutica y de dispositivos médicos. Se espera que su nombramiento mejore la supervisión de la estrategia y el valor para los accionistas por parte de la junta.
El Dr. Flemming Ornskov, Presidente de la Junta, elogió el historial comprobado de Knight en la promoción del crecimiento y la innovación. El Dr. Udit Batra, Presidente y CEO de Waters, destacó el compromiso de Knight con la excelencia operativa y su experiencia global en la ejecución comercial y la innovación del portafolio como complementos a las habilidades existentes de la junta.
Waters (NYSE:WAT)는 Heather Knight를 이사회의 이사로 임명했으며, 이는 2024년 8월 14일부터 유효합니다. Knight는 현재 Baxter International의 의료 제품 및 치료 그룹의 부사장 겸 그룹 사장으로 재직 중이며, 제약 및 의료 기기 산업에서 거의 30년의 경험을 가지고 있습니다. 그녀의 임명이 이사회의 전략 및 주주 가치를 감독하는 데 도움이 될 것으로 기대됩니다.
이사회 의장인 Flemming Ornskov 박사는 Knight의 성장과 혁신을 이끌어낸 입증된 기록을 칭찬했습니다. Waters의 사장 및 CEO인 Udit Batra 박사는 Knight가 운영 우수성에 대한 헌신과 상업 실행 및 포트폴리오 혁신에서의 글로벌 경험이 이사회의 기존 기술에 보완적이라고 강조했습니다.
Waters (NYSE:WAT) a nommé Heather Knight au sein de son Conseil d'Administration, avec effet au 14 août 2024. Knight, actuellement Vice-Présidente Exécutive et Présidente de Groupe pour les Produits et Thérapies Médicales chez Baxter International, possède près de trois décennies d'expérience dans les industries pharmaceutique et des dispositifs médicaux. Sa nomination devrait renforcer la supervision de la stratégie et de la valeur pour les actionnaires par le conseil.
Le Dr Flemming Ornskov, Président du Conseil, a salué le parcours éprouvé de Knight en matière de croissance et d'innovation. Le Dr Udit Batra, Président et Directeur Général de Waters, a souligné l'engagement de Knight envers l'excellence opérationnelle et son expérience mondiale en matière d'exécution commerciale et d'innovation de portefeuille, qui viennent compléter les compétences existantes du conseil.
Waters (NYSE:WAT) hat Heather Knight in seinen Vorstand berufen, mit Wirkung zum 14. August 2024. Knight, die derzeit als Executive Vice President und Gruppenpräsidentin für Medizinprodukte und Therapien bei Baxter International tätig ist, bringt nahezu drei Jahrzehnte Erfahrung in der pharmazeutischen und der medizinischen Gerätebranche mit. Ihre Ernennung wird voraussichtlich die Aufsicht des Vorstands über die Strategie und den Aktionärswert verbessern.
Dr. Flemming Ornskov, Vorsitzender des Vorstands, lobte Knights nachgewiesene Erfolge bei der Förderung von Wachstum und Innovation. Dr. Udit Batra, Präsident und CEO von Waters, hob Knights Engagement für operative Exzellenz und ihre globale Erfahrung in der kommerziellen Umsetzung und Portfoliomanagement hervor, die die bestehenden Fähigkeiten des Vorstands ergänzen.
- Appointment of an experienced industry leader to the Board of Directors
- Addition of diverse skills and backgrounds to enhance board oversight
- Potential for improved strategy execution and innovation
- None.
"Heather is an accomplished leader who brings decades of experience across the pharmaceutical and medical device industries, with a proven track record for driving growth and innovation," said Dr. Flemming Ornskov, Chair of the Board. "Her experience enriches the diverse skills and backgrounds of our Board members, which is instrumental in our oversight of the strategy and in enhancing shareholder value."
"We are thrilled to welcome Heather to our Board of Directors," said Dr. Udit Batra, President and CEO, Waters Corporation. "Her commitment to operational excellence coupled with her global experience driving commercial execution and portfolio innovation across the MedTech industry will be complementary to our Board. I look forward to collaborating with her as we advance our growth strategy."
"It's an honor to join the Waters Board of Directors at such an exciting time," commented Heather Knight, Executive Vice President and Group President of Medical Products and Therapies at Baxter International. "I've long admired the company and look forward to contributing to its success."
Ms. Knight currently serves as the Executive Vice President and Group President of Medical Products and Therapies at Baxter International. She brings nearly three decades of global business and commercial leadership experience in the pharmaceutical and medical device industries, and a proven track record of driving strong execution, business transformation, and portfolio innovation. She holds a B.S. in Biology from the University of Buffalo.
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT), a global leader in analytical instruments and software, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences for more than 65 years. With approximately 7,500 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.
Contact:
Kevin Kempskie
Senior Director Public Relations
Waters Corporation
pr@waters.com
+1.508.478.2000
View original content to download multimedia:https://www.prnewswire.com/news-releases/waters-corporation-appoints-heather-knight-to-board-of-directors-302222613.html
SOURCE Waters Corporation
FAQ
Who is Heather Knight, the new board member of Waters (NYSE:WAT)?
When does Heather Knight's appointment to Waters 's (NYSE:WAT) Board of Directors take effect?
What experience does Heather Knight bring to Waters 's (NYSE:WAT) Board?
How might Heather Knight's appointment impact Waters (NYSE:WAT)?
